|
EORTC/EFISG: INVASIVE ASPERGILLOSIS MANAGEMENT IN 2017 AND BEYOND - The flu becomes mouldy (click for details) |
|
|
|
Antifungal prophylaxis in immunocompromised children (click for details) |
|
|
|
Complexity of biological environment at home and respiratory symptoms in the cohort ELFE children (click for details) |
|
|
|
In host adaptation of Aspergillus fumigatus (click for details) |
|
|
|
Galactomannan (click for details) |
|
|
|
Fungal disease - And the power of stories (click for details) |
|
|
|
Epidemiology, risk factors and clinical outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss transplant cohort (click for details) |
|
|
|
Invasive aspergillosis management in 2017 and beyond: News from the lab (click for details) |
|
|
|
Therapeutic drug monitoring of triazoles (click for details) |
|
|
|
A pharmacokinetic fairy tale: Goldilocks and the three azoles (click for details) |
|
|
